EPIX Pharmaceuticals, Inc. (OP:EPIX)
0.01
-0 (-0%)
| EPIX Pharmaceuticals, Inc. (OP:EPIX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $1.87 | ||
| Open | $0.02 | 52 Week Low | $0.01 | ||
| Day High | $0.02 | P/E | N/A | ||
| Day Low | $0.01 | EPS | $-0.79 | ||
| Volume | 1,621,031 | ||||
| More EPIX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| COMV | 1 | KV.A | 1 |
| CZZ | 1 | LCAPA | 1 |
| DOW | 1 | OHI | 1 |
| FEED | 1 | PLD | 1 |
| GLD | 1 | RMBS | 1 |
| LINE | 1 | SCG | 1 |
Entities who have mentioned EPIX
- Pershing Square Capital | View Related Stories »
- Bankruptcy | View Related Stories »
- JPMorgan | View Related Stories »
- Deutsche Bank | View Related Stories »
- UBS | View Related Stories »
- Standard & Poor's | View Related Stories »
- Gabelli & Company | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Needham & Co | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- William Ackman | View Related Stories »
- 13G | View Related Stories »
- Merrill Lynch | View Related Stories »
- Raymond James | View Related Stories »
- Scopia Capital | View Related Stories »
- Maxim Group | View Related Stories »
- Wachovia | View Related Stories »
- Barron's | View Related Stories »
- Citron Research | View Related Stories »
- Dividend | View Related Stories »
- Crude Oil | View Related Stories »
- RBC Capital | View Related Stories »
- Bear Stearns | View Related Stories »
- Citi | View Related Stories »
- Jefferies & Co | View Related Stories »
View All ReportsStreetInsider.com Reports on EPIX
- EPIX Pharma (EPIX) Reports Mixed Q1 Results
- Needham & Co Downgrades EPIX Pharmaceuticals (EPIX) to Hold
- Unusual 11 Mid-Day Movers 12/29: SPIR, CZZ, PAL, SPF Higher; FEED, COMV, EPIX, DOW Lower
- Unusual 11 Mid-Day Movers 12/24: LCAPA, PLD, RMBS, VLY Higher; KV, YRCW, EPIX, VIP Lower
- EPIX Pharmaceuticals (EPIX) Receives FDA Marketing Approval for Vasovist
View All Press ReleasesCompany Press Releases on EPIX
- Joseph F. Finn, Jr., Assignee for the Benefit of Creditors of EPIX Pharmaceuticals, Inc., Releases Statement Regarding Liquidation Process
- EPIX Pharmaceuticals Announces FDA Approval of a Physician-Sponsored IND for Fourth 6-month Open Label Extension of PRX-03140 for Alzheimer's Disease Patient
- Epix Pharmaceuticals, Inc. Announces a Successful Auction Sale of Five Drug Program Intellectual Properties on September 30, 2009
StreetInsider Reports on EPIX by Category
View All BlogsBlogs on EPIX
- Epix Surrenders Battle to Keep Alzheimer's Program Afloat
- VC Financings Boost Interest in Biotech
- FDA, Clinical Trial Calendar Updates: SOMX, EPIX, HLUKY, ARKTF
- Updated FDA Decision Calendar: Five Decisions Before Year-End
- EPIX Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
Comments on EPIX
No comments are currently available.
